| Anticoagulant Reagents |
| Product | Product # |
| Heparin sodium salt bovine intestinal mucosa ³140 USP units/mg | H0777 |
| Heparin sodium salt from porcine intestinal mucosa Grade I-A ~170 USP units/mg | H3393 |
| Citrate-phosphate-dextrose solution with adenine | C4431 |
| Citrate-phosphate-dextrose solution aseptically filled | C7165 |
| Citrate-dextrose solution (ACD) sterile-filtered | C3821 |
| Ethylenediaminetetraacetic acid disodium salt solution 2% solution | 285-4 |
| Polyanetholesulfonic acid sodium salt powder | P2008 |
| Sodium citrate tribasic solution 4 % (w/v) | S5770 |
| Factor V | back to top |
| Product | Product # |
| Activator | |
| Factor V Activating Enzyme Russell's viper venom lyophilized powder 20 units/mg protein (E1%, 10.0 at 280 nm) | F3380 |
| Factor VIII | back to top |
| Product | Product # |
| Inhibitor | |
| Acetyl-Ala-Leu-Cys-Asp-Asp-Pro-Arg-Val-Asp-Arg-Trp-Tyr-Cys-Gln-Phe-Val-Glu-Gly-NH2 [Disulfide bridge: 3-13] ³95% (HPLC) | A0472 |
| Factor IX | back to top |
| Product | Product # |
| Factor IX human, lyophilized powder | F0650 |
| Factor X | back to top |
| Product | Product # |
| Enzyme | |
| Factor X bovine plasma, buffered aqueous solution ~80 units/mg protein (E1%, 12.4 at 280 nm) | F4003 |
| Factor X Activated (Xa) bovine plasma, lyophilized powder | F2027 |
| Inhibitor | |
| 3,4-Dichloroisocoumarin | D7910 |
| a2-Antiplasmin from human plasma lyophilized powder ³5 inhibitor U/mg protein | A0914 |
| Antithrombin III from bovine plasma, lyophilized powder 200-400 units/mg protein (E1%/280 = 6.5) | A9141 |
| Antithrombin III from human plasma ³95% (SDS-PAGE) lyophilized powder | A2221 |
| Antithrombin III from rat plasma, lyophilized powder >200 units/mg protein (E1%/280 = 6.5) | A6397 |
| Diisopropyl fluorophosphate | D0879 |
| Ecotin recombinant, expressed in Escherichia coli ³90% (SDS-PAGE) essentially salt-free, lyophilized powder ³2000 units/mg protein | E1398 |
| Substrate | |
| Factor Xa chromogenic substrate solid | F3301 |
| Factor XII | back to top |
| Product | Product # |
| Inhibitor | |
| Esterase inhibitor C-1 from human plasma, >95% (SDS-PAGE) buffered aqueous solution | E0518 |
| Fibrin/Fibrinogen | back to top |
| Product | Product # |
| Fibrin | |
| Fibrin from human plasma | F5386 |
| Fibrinogen | |
| Fibrinogen from bovine plasma Type IV | F4753 |
| Fibrinogen from bovine plasma Type I-S powder | F8630 |
| Fibrinogen from cat plasma | F8513 |
| Fibrinogen from canine plasma | F7128 |
| Fibrinogen from human plasma Type I | F3879 |
| Fibrinogen from human plasma Type III | F4129 |
| Fibrinogen from human plasma, Essentially plasmin(ogen) free powder | F4883 |
| Fibrinogen from murine plasma | F4385 |
| Fibrinogen from porcine plasma | F2629 |
| Fibrinogen from rat plasma | F6755 |
| Fibrinogen from sheep plasma | F9754 |
| Inhibitor | |
| N-Acetyl-Pen-Arg-Gly-Asp-Cys [Disulfide bridge: 1-5] ³97% (HPLC) | A5582 |
| Related Peptides | |
| Gly-Pro-Arg-Pro ³97% (HPLC) | G1895 |
| Gly-Pro-Arg-Pro amide ³97% (HPLC) | G5779 |
| Fibrinogen-binding Inhibitor Peptide ³97% (HPLC) | F9145 |
| Fibrinopeptide A ³97% (HPLC) | F3254 |
| Fibrinopeptide B Human ³97% (HPLC) | F3379 |
| [Glu1]-Fibrinopeptide B human ³90% (HPLC) | F3261 |
| Kallikrein | back to top |
| Product | Product # |
| Enzyme | |
| Kallikrein from porcine pancreas ³40 units/mg solid | K3627 |
| Kininogen | back to top |
| Product | Product # |
| Kininogen High Molecular Weight, Two Chain from human plasma lyophilized powder | K1632 |
| Kininogen, low molecular weight from human plasma >95% (SDS-PAGE) lyophilized powder | K3628 |
| Plasmin/Plasminogen | back to top |
| Product | Product # |
| Activator | |
| Glu-Gly-Arg chloromethyl ketone ³90% (HPLC) powder | G2917 |
| Streptokinase β-hemolytic Streptococcus (Lancefield Group C), lyophilized powder | S3134 |
| Streptokinase β-hemolytic Streptococcus (Lancefield Group C), buffered aqueous solution ~100,000 units/mg protein | S8026 |
| Tissue plasminogen activator chromogenic substrate ³95% (HPLC) solid | T2943 |
| Tissue Plasminogen Activator | T4825 |
| Inhibitor | |
| a2-Antiplasmin from human plasma lyophilized powder ³5 inhibitor U/mg protein | A0914 |
| Aprotinin bovine lung, lyophilized powder 3-7 TIU/mg solid | A1153 |
| 3,4-Dichloroisocoumarin | D7910 |
| 4-(2-Aminoethyl)benzenesulfonyl fluoride hydrochloride ~97% | A8456 |
| 6-Aminohexanoic acid, >99% (titration) powder | A2504 |
| 6-Aminohexanoic acid, SigmaUltra >99% | A7824 |
| α2-Macroglobulin from human plasma, >98% (SDS-PAGE) lyophilized powder | M6159 |
| α2-Antiplasmin from human plasma, lyophilized powder >5 inhibitor U/mg protein | A0914 |
| Antipain dihydrochloride microbial source | A6191 |
| Antithrombin III from bovine plasma, lyophilized powder 200-400 units/mg protein (E1%/280 = 6.5) | A9141 |
| Antithrombin III from human plasma ³95% (SDS-PAGE) lyophilized powder | A2221 |
| Aprotinin bovine lung, lyophilized powder 3-7 TIU/mg solid | A1153 |
| Bdellin from leeches lyophilized powder >0.1 IU/mg protein (E280) | B3906 |
| Diisopropyl fluorophosphate | D0879 |
| Elastatinal microbial ~50% | E0881 |
| Esterase inhibitor C-1 from human plasma, >90% (SDS-PAGE) | C2412 |
| Esterase inhibitor C-1 from human plasma, >95% (SDS-PAGE) buffered aqueous solution | E0518 |
| Gabexate mesylate solid | G2417 |
| Leupeptin trifluoroacetate salt, >90% (HPLC) microbial | L2023 |
| Phenylmethanesulfonyl fluoride, >99% (GC) | P7626 |
| Urinary Trypsin Inhibitor Fragment, >95% (HPLC) | U4751 |
| Plasmin | |
| Plasmin from human plasma | P1867 |
| Plasminogen | |
| Plasminogen from rabbit plasma, lyophilized powder 4-10 units/mg protein | P2284 |
| Plasminogen bovine plasma, not suitable for streptokinase determination by clot formation procedure lyophilized powder 3-5 units/mg protein | P9156 |
| Plasminogen from human plasma, suitable for streptokinase determination by clot formation procedure lyophilized powder >2 units/mg protein | P5661 |
| Plasminogen from human plasma, not suitable for streptokinase determination by clot formation procedure lyophilized powder >2 units/mg protein | P7397 |
| Receptor | |
| Urokinase-type Plasminogen Activator Receptor-1/Fc Chimera from mouse, recombinant, expressed in mouse NSO cells >90% (SDS-PAGE) lyophilized powder | U9757 |
| Substrate | |
| Boc-Val-Leu-Lys-7-amido-4-methylcoumarin | B1136 |
| D-Ala-Leu-Lys-7-amido-4-methylcoumarin 95% (HPLC) | A8171 |
| D-Ile-Phe-Lys p-nitroanilide, >95% (HPLC) | I6886 |
| D-Val-Leu-Lys 4-nitroanilide dihydrochloride | V0882 |
| Gly-Arg-p-nitroanilide dihydrochloride | G8148 |
| N-(p-Tosyl)-Gly-Pro-Lys 4-nitroanilide acetate salt | T6140 |
| Z-Ala-Ala-Lys 4-methoxy-b-naphthylamide formate salt | C2147 |
| D-Val-Leu-Lys 4-methoxy-2-naphthylamide solid | V3263 |
| D-Val-Leu-Lys 7-amido-4-methylcoumarin ³99% (HPLC) lyophilized powder | V3138 |
| D-Val-Leu-Lys 7-amido-4-trifluoromethylcoumarin lyophilized powder | V3013 |
| D-Val-Phe-Lys p-Nitroanilide dihydrochloride ³97% (HPLC) | V6884 |
| pGlu-Gly-Arg-7-amido-4-trifluoromethylcoumarin ³95% (HPLC) lyophilized powder | P5615 |
| Tissue plasminogen activator chromogenic substrate ³95% (HPLC) solid | T2943 |
| Gly-Arg-p-nitroanilide dihydrochloride | G8148 |
| N-Benzoyl-Val-Gly-Arg p-nitroanilide hydrochloride | B4758 |
| N-Glutaryl-Gly-Arg-7-amido-4-methylcoumarin hydrochloride | G2386 |
| pGlu-Gly-Arg-7-amido-4-trifluoromethylcoumarin ³95% (HPLC) lyophilized powder | P5615 |
| Z-Gly-Gly-Arg 4-methoxy-b-naphthylamide hydrochloride | C5770 |
| Z-Gly-Gly-Arg 7-amido-4-methylcoumarin hydrochloride | C9396 |
| Platelet Activators | back to top |
| Product | Product # |
| Activator | |
| Ristomycin monosulfate >90% as ristocetin A (balance primarily Ristocetin B) | R7752 |
| Protein C | back to top |
| Product | Product # |
| Enzyme | |
| Protein C human, lyophilized powder | P2562 |
| Protein C human plasma, Activated >90% (SDS-PAGE) lyophilized powder | P2200 |
| Thrombin/Prothrombin (Factor II) | back to top |
| Product | Product # |
| Activator | |
| Ecarin from Echis carinatus venom | E0504 |
| Enzyme | |
| Factor II human plasma lyophilized powder 5-20 units/mg protein (E1%, 15.5 at 280 nm) | F5132 |
| Agkistrodon contortrix thrombin-like enzyme, lyophilized powder | A8766 |
| Ancrod from Agkistrodon rhodostoma (Malayan pit viper) venom lyophilized powder ³200 NIH units/mg protein (E1%, 14.8 at 280 nm) | A5042 |
| Thrombin bovine plasma, lyophilized powder 50-150 NIH units/mg protein | T3399 |
| Thrombin bovine plasma, lyophilized powder 175-350 NIH units/mg protein (biuret) | T4265 |
| Thrombin bovine plasma, lyophilized powder 40-165 NIH units/mg protein (biuret) | T4648 |
| Thrombin bovine plasma lyophilized powder ³2,000 NIH units/mg protein (E1%/280 = 19.5) | T7513 |
| Thrombin bovine plasma, >125 NIH units/mg protein (biuret) | T9000 |
| Thrombin bovine plasma lyophilized powder ³700 NIH units/mg protein (Bradford) | T9681 |
| Thrombin from human plasma, lyophilized powder 50-300 NIH units/mg protein | T0553 |
| Thrombin from human plasma lyophilized powder >2800 NIH units/mg protein (E1%/280 = 18.3, 18.3 at 280 nm) | T1063 |
| Thrombin from human plasma, cell culture tested lyophilized powder ~1,000 NIH units/mg protein (E1%, 18.3 at 280 nm) | T4393 |
| Thrombin from human plasma lyophilized powder ³2,000 NIH units/mg protein (E1%, 18.3 at 280 nm) | T6884 |
| Thrombin from human plasma lyophilized powder ~1,000 NIH units/mg protein (E1%, 18.3 at 280 nm) | T7009 |
| Thrombin from human plasma, lyophilized powder Suitable for routine use in the thrombin time test | T8885 |
| Thrombin from human plasma, lyophilized powder Suitable for routine use in the thrombin time test | T9135 |
| Thrombin from human plasma lyophilized powder 50-300 NIH units/mg protein | T9677 |
| Thrombin from murine plasma lyophilized powder ~1,000 NIH units/mg protein (biuret) | T8397 |
| Inhibitor | |
| [Lys47]Hirudin (HV2), leech, recombinant, expressed in Saccharomyces cerevisiae 7,000-14,000 ATU/mg protein (ATU = antithrombin units) | H0393 |
| 3,4-Dichloroisocoumarin | D7910 |
| 4-(2-Aminoethyl)benzenesulfonyl fluoride hydrochloride, ~97% | A8456 |
| a2-Antiplasmin from human plasma lyophilized powder ³5 inhibitor U/mg protein | A0914 |
| Antipain dihydrochloride microbial source | A6191 |
| Antithrombin III from bovine plasma, lyophilized powder 200-400 units/mg protein (E1%/280 = 6.5) | A9141 |
| Antithrombin III from human plasma ³95% (SDS-PAGE) lyophilized powder | A2221 |
| Antithrombin III from rat plasma, lyophilized powder >200 units/mg protein (E1%/280 = 6.5) | A6397 |
| Diisopropyl fluorophosphate | D0879 |
| D-Val-Leu-Lys-chloromethyl ketone ³90% (HPLC) white powder | V3763 |
| Gabexate mesylate solid | G2417 |
| Hirudin leeches ³1,500 ATU/mg protein (ATU = antithrombin units) | H7016 |
| Hirudin leeches lyophilized powder 300-1,500 ATU/mg protein (ATU = antithrombin units) | H7380 |
| Hirudin leeches lyophilized powder ³6,000 ATU/mg protein (ATU = antithrombin units) | H9022 |
| [Tyr(SO3H)63]-Hirudin Fragment 54-65 ³95% (HPLC) | H6894 |
| [Tyr(SO3H)63]-Hirudin Fragment 55-65 ³97% (HPLC) | H8894 |
| Leupeptin trifluoroacetate salt, >90% (HPLC) microbial | L2023 |
| Na-(2-Naphthalenesulfonylglycyl)-4-amidino-DL-phenylalaninepiperidide 0.1 µmole/mg solid (balance glycine) | N8514 |
| N-Acetyl-eglin C recombinant, expressed in unspecified host | E7888 |
| Nα-p-Tosyl-L-lysine chloromethyl ketone hydrochloride, >96% (TLC) powder | T7254 |
| Phenylmethanesulfonyl fluoride, >99% (GC) | P7626 |
| Antithrombin III from bovine plasma, lyophilized powder 200-400 units/mg protein (E1%/280 = 6.5) | A9141 |
| Antithrombin III from human plasma ³95% (SDS-PAGE) lyophilized powder | A2221 |
| Related Proteins | |
| Protein Z human plasma liquid | P7489 |
| Substrate | |
| 4-Methylumbelliferyl 4-guanidinobenzoate hydrochloride hydrate crystalline | M4149 |
| Boc-b-benzyl-Asp-Pro-Arg-7-amido-4-methylcoumarin hydrochloride ~95% | B4028 |
| Boc-Val-Pro-Arg-7-amido-4-methylcoumarin hydrochloride | B9385 |
| N-(p-Tosyl)-Gly-Pro-Arg p-nitroanilide acetate salt | T1637 |
| N-Benzoyl-Phe-Val-Arg 4-methoxy-b-naphthylamide hydrochloride | B1260 |
| N-Benzoyl-Phe-Val-Arg-p-nitroanilide hydrochloride | B7632 |
| N-p-Tosyl-Gly-Pro-Arg 7-amido-4-methylcoumarin hydrochloride | T0273 |
| Sar-Pro-Arg p-nitroanilide dihydrochloride | S9009 |
| Thrombin generation chromogenic substrate ³90% (TLC) solid | T3068 |
